Reduction of Raf Kinase Inhibitor Protein Expression by Bcr-Abl Contributes to Chronic Myelogenous Leukemia Proliferation
Open Access
- 26 February 2010
- journal article
- Published by Elsevier BV
- Vol. 285 (9), 6585-6594
- https://doi.org/10.1074/jbc.m109.075788
Abstract
No abstract availableThis publication has 52 references indexed in Scilit:
- Phospho-ERK Staining Is a Poor Indicator of the Mutational Status of BRAF and NRAS in Human MelanomaJournal of Investigative Dermatology, 2008
- The G protein-coupled receptor kinase (GRK) interactome: Role of GRKs in GPCR regulation and signalingBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007
- RKIP does not contribute to MAP kinase pathway silencing in the Merkel Cell Carcinoma cell line UISOJournal of Carcinogenesis, 2007
- The RAF proteins take centre stageNature Reviews Molecular Cell Biology, 2004
- Raf kinase inhibitory protein inhibits β-cell proliferationSurgery, 2004
- Seven-transmembrane receptorsNature Reviews Molecular Cell Biology, 2002
- Raf Kinase Inhibitor Protein Interacts with NF-κB-Inducing Kinase and TAK1 and Inhibits NF-κB ActivationMolecular and Cellular Biology, 2001
- Crystal structures of YBHB and YBCL from Escherichia coli, two bacterial homologues to a Raf kinase inhibitor proteinJournal of Molecular Biology, 2001
- The Molecular Genetics of Philadelphia Chromosome–Positive LeukemiasThe New England Journal of Medicine, 1988
- DNA Contents of Chromosome Ph 1 and Chromosome 21 in Human Chronic Granulocytic LeukemiaScience, 1964